@Article{dbt_mods_00068064, author = {Eshaghi, Ghazaleh and Kaiser, David and Rasouli, Hamid Reza and Ennaciri, Rania and Frey, Martha and Neumann, Christof and Gary, Dominik and Fischer, Tobias and Frankenfeld, Katrin and Turchanin, Andrey}, title = {Highly sensitive and label-free detection of SARS-CoV-2 proteins via surface plasmon resonance using biofunctionalization with 1 nm thick carbon nanomembranes}, journal = {Scientific reports}, year = {2025}, month = {Aug}, day = {25}, publisher = {Macmillan Publishers Limited, part of Springer Nature}, address = {London}, volume = {15}, number = {1}, pages = {1--12}, keywords = {Biosensors; SARS-CoV-2; Surface plasmon resonance; Two-dimensional materials; Carbon nanomembrane; Surface functionalization}, abstract = {Here we report a novel platform for the detection of nucleocapsid (N) and receptor-binding domain (RBD) of spike (S) proteins of SARS-CoV-2 viruses using the surface plasmon resonance (SPR) technique. We demonstrate that the functionalization of SPR sensors with molecular 2D materials − 1 nm thick carbon nanomembranes (CNMs) significantly enhances sensitivity. CNMs terminated with azide linker (N 3 -CNM) enable covalent bonding of SARS-CoV-2 antibodies for specific immobilization of the N- and S-proteins to the sensor surface. The successful and stable hierarchical functionalization is confirmed by multiparametric SPR measurements complemented with X-ray photoelectron spectroscopy and polarization modulation infrared reflection absorption spectroscopy. The obtained equilibrium dissociation constants ( K D ) for the N-protein and the S-protein in the physiological buffer are 570{\thinspace}{\textpm}{\thinspace}50 pM and 22{\thinspace}{\textpm}{\thinspace}2 pM and the low detection limits ( LOD s) are {\~}{\thinspace}190 pM and {\~}{\thinspace}10 pM, respectively. The high specificity of the developed sensors is shown via their negligible cross-reactivity with SARS-CoV-1 and MERS-CoV proteins. Finally, detection of SARS-CoV-2 proteins in nasopharyngeal swab samples with the LOD of {\~}{\thinspace}40 pM is demonstrated. The proposed methodology enables the development of biosensors that cover clinically relevant range for the direct and immediate detection of SARS-CoV-2 without any amplification or labeling.}, note = {Zweitver{\"o}ffentlichung}, issn = {2045-2322}, doi = {10.1038/s41598-025-16342-5}, url = {https://www.db-thueringen.de/receive/dbt_mods_00068064}, url = {http://uri.gbv.de/document/gvk:ppn:663366712}, url = {https://doi.org/10.1038/s41598-025-16342-5}, file = {:https://www.db-thueringen.de/servlets/MCRFileNodeServlet/dbt_derivate_00069478/41598_2025_Article_16342.pdf:PDF}, language = {en} }